🇺🇸 FDA
Patent

US 11649207

Formulations of T-type calcium channel modulators and methods of use thereof

granted A61KA61K31/445A61K47/38

Quick answer

US patent 11649207 (Formulations of T-type calcium channel modulators and methods of use thereof) held by PRAXIS PRECISION MEDICINES, INC. expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRAXIS PRECISION MEDICINES, INC.
Grant date
Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/445, A61K47/38, A61K9/0053, A61K9/2009